Logo

Exploring the Side Effects and Drug-Drug Interactions Resulting from Polypharmacy: A Case Study from Cardiovascular Pharmacotherapy

Authors
  • Issa E. A. Amara

    Department of Pharmacology, Faculty of Medicine, University of Zintan, Libya
    Author
    https://orcid.org/0000-0002-0780-8737
  • Malak Aburas

    Faculty of Medicine, Uni-versity of Gharyan, Libya
    Author
  • Shaban E. A. Saad

    Department of Pharmacology, Faculty of Pharmacy, University of Tripoli, Libya
    Author
Keywords:
Drug-drug interactions, Polypharmacy, Drug Side Effects, Case Study
Abstract

In clinical practice, it is standard procedure to assess potential drug-drug interactions (DDIs) when prescribing multiple medications to a single patient. The prevalence of DDIs escalates with an increased number of concurrently prescribed drugs. Polypharmacy, as defined by the World Health Organization, entails the administration of numerous medications simultaneously, or an excessive number of medications. We postulate a close association between polypharmacy and DDIs. This study presents a singular case investigation encompassing a comprehensive review of all prescribed and over-the-counter medications, medical history, and laboratory results, coupled with an extensive cross-referencing with existing literature to identify DDIs associated with polypharmacy. Our findings underscore a robust positive correlation between polypharmacy and DDIs, with a total of 83 documented instances. Notably, antibiotics emerged as the medication class responsible for the highest number of DDIs, accounting for 13 cases.

Downloads
Download data is not yet available.
Author Biographies
  1. Issa E. A. Amara, Department of Pharmacology, Faculty of Medicine, University of Zintan, Libya

    Assistant Professor, Department of Pharmacology, University of Zintan and University of Gharyan 

  2. Malak Aburas , Faculty of Medicine, Uni-versity of Gharyan, Libya

    MSc. Student  

  3. Shaban E. A. Saad , Department of Pharmacology, Faculty of Pharmacy, University of Tripoli, Libya

    Professor of Pharmacology, Department of Pharmacology, School of Pharmaceutics, University of Tripoli

References

Fleg, J. L., Aronow, W. S., & Frishman, W. H. (2011). Cardiovascular drug therapy in the elderly: benefits and challenges. Nature Reviews Cardiology, 8(1), 13–28.

Gómez, C., Vega-Quiroga, S., Bermejo-Pareja, F., Medrano, M. J., Louis, E. D., & Benito-León, J. (2015). Polypharmacy in the elderly: a marker of increased risk of mortality in a population-based prospective study (NEDICES). Gerontology, 61(4), 301–309.

Hines, L. E., & Murphy, J. E. (2011). Potentially harmful drug–drug interactions in the elderly: a review. The American Journal of Geriatric Pharmacotherapy, 9(6), 364–377.

Johnell, K., & Klarin, I. (2007). The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600 000 elderly patients from the Swedish prescribed drug register. Drug Safety, 30, 911–918.

Khezrian, M., McNeil, C. J., Murray, A. D., & Myint, P. K. (2020). An overview of prevalence, determinants and health outcomes of polypharmacy. Therapeutic Advances in Drug Safety, 11, 2042098620933741.

Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatrics, 17, 1–10.

Seymour, R. M., & Routledge, P. A. (1998). Important drug-drug interactions in the elderly. Drugs & Aging, 12, 485–494.

Yazdanyar, A., & Newman, A. B. (2009). The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clinics in Geriatric Medicine, 25(4), 563–577.

Cover Image
Downloads
Published
2024-12-31
Section
Articles
License

Copyright (c) 2024 Issa E. A. Amara, Malak Aburas , Shaban E. A. Saad (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright of the articles Published by Almukhtar Journal of Science (MJSc) is retained by the author(s), who grant MJSc a license to publish the article. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors and cite MJSc as the original publisher. Also, they accept the article remains published by the MJSc website (except in the occasion of a retraction of the article). 

How to Cite

Amara, I. E. A. ., Aburas, M. I., & Saad, S. E. A. . (2024). Exploring the Side Effects and Drug-Drug Interactions Resulting from Polypharmacy: A Case Study from Cardiovascular Pharmacotherapy. Al-Mukhtar Journal of Sciences, 39(3), 164-171. https://doi.org/10.54172/f4r0h750

Similar Articles

21-30 of 41

You may also start an advanced similarity search for this article.